About Us
Author Guidelines
Contact Us
Supplier Info
 


Current Issue
Sample issue of JATCurrent Issue


Contact Info:
6600 W. Touhy Ave.
Niles, IL 60714
Tel: 847.647.2900
Fax: 847.647.1155
circulation@jatox.com

 

 
   

Journal of Analytical Toxicology Article Abstracts

Journal of Analytical Toxicology Horizontal Line

Published: Journal of Analytical Toxicology, ISSN 0146-4760, Volume 24, Number 4, May/June 2000, pp.245-249

Solid-Phase Extraction of 11-Nor-D9-Tetrahydrocannabinol-9-Carboxylic Acid from Urine Drug-Testing Specimens with the Cerex PolyCrom-THC™ Column Confirmation of drugs of abuse by gas chromatography–mass spectrometry (GC–MS) is the most time-consuming process used by drug-testing laboratories. Cost effectiveness and competitive turnaround times for testing results demand fast, efficient, and reliable extraction methods. We applied the Cerex Polycrom-THC solid-phase extraction (SPE) column to the extraction of 11-nor-D9-tetrahydrocannabinol carboxylic acid (9-THCA) from urine. This column uses an anion exchange divinyl-benzene copolymer, which requires no pH adjustment after hydrolysis of the THC-glucuronide with base, as is necessary with many other SPE columns. With urine, no preconditioning of the SPE column was necessary. After extraction, trimethylsilyation derivatization was performed with N-methyl-N-(trimethylsilyl) trifluoroacetamide. This further improved efficiency because no heated incubation was required. A method correlation to an existing liquid–liquid extraction was performed. Analysis was on a Finnigan Voyager GC–MS with a 2.5-min run time per injection. Using 9-THCA-d9 deuterated internal standard, the assay was linear from 2 to 2000 ng/mL. Total precision at the 15-ng/mL cutoff concentration was 4.4%. The Cerex column was also evaluated for interference using two common drug-test adulterants, Klear™ and Urine Luck™. Considerably less interference was observed when compared to an existing liquid–liquid method.David K. Crockett1, Gordon Nelson2, Philip Dimson3, and Francis M. Urry1,4
1ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, Utah 84108; 2General Medical Laboratories, Madison, Wisconsin 53715; 3SPEware, San Pedro, California 90732; and 4Department of Pathology, University of Utah School of Medicine, Salt Lake City, Utah 84112

Reproduction of editorial content of this journal is prohibited without publisher’s permission.

This article is available in its entirety by fax for $4.00 per page.
Visa or MasterCard accepted.

To order electronically click here
or call: 847-647-2900 ext. 1323
or fax request to: 847-647-1155.

Please indicate JAT volume and issue along with page numbers.


| Home | Subscribe | Current Issue | Back Issues | Search | Advertise | Other Publications |